SCHEMBL18535535

SCHEMBL18535535

CCCCCc1ccc(-c2cc3ccc(OC)cc3oc2=O)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
ACHE P22303 2/20 0.48
MAOA P21397 3/20 0.47
CYP2C19 P33261 1/20 0.47
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GPR55 Q9Y2T6 1/20 0.45
ALK Q9UM73 1/20 0.44
CA12 O43570 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CA2 P00918 1/20 0.44
GLA P06280 1/20 0.44
CA3 P07451 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA7 P43166 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18535674 0.99 MAOB (0.49) MAOBNPC1RAB9AACHEMAOA
SCHEMBL18535678 0.88 NPC1 (0.51) MAOBNPC1RAB9AACHEMAOA
SCHEMBL23713548 0.87 NPC1 (0.50) MAOBNPC1RAB9AACHEMAOA
SCHEMBL23713512 0.85 NPC1 (0.47) MAOBNPC1RAB9AACHEMAOA
SCHEMBL21524274 0.84 NPC1 (0.64) MAOBNPC1RAB9AACHEMAOA
SCHEMBL21524272 0.83 NPC1 (0.46) MAOBNPC1RAB9AACHEMAOA
SCHEMBL23542234 0.83 NPC1 (0.46) MAOBNPC1RAB9AACHEMAOA
SCHEMBL7123865 0.81 NPC1 (0.60) MAOBNPC1RAB9AACHEMAOA
SCHEMBL18554377 0.79 NPC1 (0.51) MAOBNPC1RAB9AACHEMAOA
SCHEMBL23713533 0.79 GLA (0.48) MAOBNPC1RAB9AMAOAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363122-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2021-11-25 US disclosed
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed
US-10457658-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2019-10-29 US disclosed
WO-2017032442-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2017-03-02 WO disclosed
EP-3133065-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES Merck Patent GmbH (DE) 2017-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363122-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES PDE6C, ALDH1A2, PDE6A MAOB 212/4885NPC1 2482/4885RAB9A 930/4885
US-10457658-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A MAOB 212/4885NPC1 2482/4885RAB9A 930/4885
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A MAOB 212/4885NPC1 2482/4885RAB9A 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.